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Abstract
Cardiovascular magnetic resonance (CMR) phase contrast imaging has undergone a wide range of changes with
the development and availability of improved calibration procedures, visualization tools, and analysis methods.
This article provides a comprehensive review of the current state-of-the-art in CMR phase contrast imaging
methodology, clinical applications including summaries of past clinical performance, and emerging research and
clinical applications that utilize today’s latest technology.
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Introduction
The assessment of blood flow parameters is important
to the study of cardiovascular function and to the clin-
ical evaluation of cardiovascular disease. Evaluation of
the heart valves requires identification and quantification
of stenoses and regurgitation, and congenital cardiac ab-
normalities require identification and quantification of
shunt flow. Building on early developments in NMR and
MRI that enabled the measurement of flow velocity and
velocity distributions [1–3], applications of MRI to flow
assessment in cardiovascular disease began in the mid
1980s [4–9], first to the assessment of flow in the heart,
and later to the large vessels (e.g., aorta, carotids). Many
technological innovations have led to the ability to reli-
ably quantify regurgitant and shunt flow volumes,
visualize 3D time-resolved flow patterns, and assess cor-
onary flow reserve, wall shear stress, and turbulence.
Cardiovascular MR (CMR) has become an important
complement to echocardiography in the clinic, and in
the evaluation of congenital heart disease (CHD) in cen-
ters with the required expertise. In cardiovascular re-
search, CMR flow imaging is enabling a range of
emerging applications such as assessment of vessel com-
pliance and myocardial motion.
This article describes the current state-of-the-art in
CMR flow imaging methods and applications. The first
section covers methodology and technical issues including
pulse sequences, calibration, visualization, and analysis.
This section includes practical advice appropriate for both
research and clinical users. The second section covers two
major clinical applications, valvular disease and congenital
disease. These applications rely on imaging methods that
have been thoroughly validated, and are feasible with com-
mercially available pulse sequences and analysis software.
The third section covers emerging applications and tech-
nologies that have the potential to impact clinical medi-
cine and/or basic cardiovascular research.
This article will also address several common questions:
What is the best way to avoid or correct velocity offsets
and other artifacts? What is the impact of high-field sys-
tems and parallel imaging? What visualization tools have
been found to be the most informative?
I. Methodology
Physical principles and imaging methods
MRI is a phase-sensitive modality that can encode infor-
mation about velocity into the phase of the detected sig-
nal. Flow volume is typically measured by obtaining a
thin, cross-sectional image of the vessel of interest using
phase contrast methods that are sensitized to through-
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plane velocity [6, 10–12]. The vessel lumen is covered by
a set of pixels. We calculate the flow Qi through pixel i
by forming the product
Qi¼aiv⊥i ð1Þ
where v⊥i is the measured, perpendicular component of
the fluid velocity through the ith pixel, which has area
ai. The measured velocity v⊥i is in practice a weighted
average of velocities within the pixel. The total flow Q
through the vessel is then calculated by summing over
the N pixels that cover the vessel lumen in the image.
The pixel areas are typically identical (i.e., ai = a), and
can be removed from the summation:
Qtot ¼
XN
i¼1
Qi ¼
XN
i¼1
aiv⊥i ¼ a
XN
i¼1i
v⊥i ¼ ðNaÞ 1N
XN
i¼1
v⊥i
" #
¼ A〈v⊥〉
ð2Þ
Equation 2 shows that the net flow is given by the
product of the area of the vessel lumen A =Na and the
average perpendicular component of velocity 〈v⊥〉 over
the vessel lumen. If 〈v⊥〉 is measured in units of cm/s
and A is measured in units of cm2, then to express Q in
units of mL/min requires a multiplicative conversion
factor of 60 s/min.
Phase-contrast velocity mapping
Consider a single slice acquired at a single cardiac phase.
To obtain the velocity map (i.e., an image where pixel
intensity is proportional to v⊥i), a flow-encoding gradient
is applied along the slice-selection direction of the imaging
pulse sequence, after the excitation but before the readout.
Figure 1 shows representative pulse sequence diagrams for
the slice-selection gradient axis. The flow-encoding gradi-
ent can be applied as an additional pair of toggled, bipolar
gradient lobes. Alternatively, those lobes can be combined
with slice selection gradient waveforms, in order to reduce
the minimum echo time. The typical acquisition is 2DFT
gradient recalled echo (GRE) with either a full echo or
a partial echo in the readout direction. Other k-space
acquisition trajectories, including echo planar [13, 14],
spiral [15, 16] and radial [17], have been employed to
improve acquisition speed or to reduce flow artifacts.
Spins that flow along the direction of the flow-encoding
gradient accumulate phase ϕi = γm1v⊥i + ϕ0i, where γ is
the gyromagnetic ratio in units of rad/s/T, and m1 is the
first moment of the flow-encoding gradient (i.e. the time-
weighted sum of the gradient area, m1 = ∫G(t)tdt). The
term ϕ0i represents all contributions to the MR phase that
are not related to flow. This includes phase due to off-
resonance, complex RF coil receive sensitivities, and the
effect of imperfect echo centering in the readout window.
When the gradient waveform is toggled between two
shapes A and B, as indicated in Fig. 1, the change in first
moment is given by m1A and m1B so that for each pixel:
Δϕi ¼ ϕiA−ϕiB ¼ γΔm⊥v⊥i ð3Þ
To a good approximation, the confounding contribution
to the phase ϕ0i drops out of Eqn. 3, while the resulting
Fig. 1 MR images are sensitized to measure the through-plane component of velocity by applying a flow-encoding gradient to the
slice-selection axis of the pulse sequence. The flow encoding gradient can be added as (top) a bipolar pair to a flow-compensated slice
selection waveform, or (bottom) to reduce minimum TE, combined with other gradient lobes
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expression for Δϕ remains proportional to v⊥i. As discussed
in more detail later, some residual contributions to ϕ0i, not-
ably those from gradient eddy currents and from the con-
comitant field, are not completely canceled by the
subtraction operation in Eqn. 3 and usually require further
correction with post-processing.
Two complete sets of raw image data are acquired, A
and B, with a difference in gradient first moment Δm1. A
phase difference reconstruction [18, 19] is then applied to
the two raw data sets to obtain an image where the inten-
sity of the ith pixel is proportional to the velocity v⊥i. The
sign of Δϕi represents the flow direction. A magnitude
image M is reconstructed from the same raw data, either
by averaging the reconstructed magnitude images MA and
MB, or by using MA exclusively, provided acquisition A is
flow-compensated (i.e., m1A = 0). Because the gyromag-
netic ratio constant γ and the factor Δm1 are known, we
can quantitatively extract the value of v⊥i using Eqn. 3.
Acquisition considerations
A single slice location is sufficient to quantify flow
through a vessel using the method suggested by Eqn. 2.
The slice is prescribed in an oblique plane so that it per-
pendicularly intersects the vessel of interest. Although
we should always strive for perfect slice orientation, for
sufficiently thin slices (e.g., 3 mm-thick or less), the mea-
sured flow rate is relatively insensitive to small angular
deviations from true perpendicular (e.g., β < 20o). This
insensitivity arises because, to first order, errors in two
multiplicative factors in Eqn. 2 cancel: 〈v⊥〉 is reduced by
a factor of cosβ, while the area A is increased by a factor
of (cosβ)−1 [20, 21].
A time-resolved or multiphase acquisition is required to
accurately quantify pulsatile, arterial flow. To enable the
acquisition of a slice location within a breath hold (e.g.,
approximately 18 heartbeats), a segmented [22] acquisi-
tion is often used. For example, if we acquire 6 phase en-
coding lines (views) per segment, then during the first R-R
interval, flow encodings A and B for views 1-6 are repeat-
edly acquired to yield approximately 10-20 cardiac phases,
depending on the patient’s heart rate and details of the
pulse sequence and the performance specifications of the
scanner hardware. In the second R-R interval, data for
views 7-12 are acquired, and so on, until the entire k-
space is filled for both flow encodings A and B. The result-
ing multiphase phase contrast data are often recon-
structed using view sharing to increase the apparent
temporal resolution [23–25].
Flow-related aliasing
The measured velocity component v⊥i provides an excel-
lent approximation to the true, average velocity compo-
nent within the voxel [20, 26] unless flow-related
aliasing occurs. The aliasing velocity is an operator-
selected parameter of the phase contrast pulse sequence.
It is often denoted by venc or VENC, which is the maximum
encoded velocity and is measured in units of cm/s. Pro-
vided the average perpendicular component of velocity
within a voxel lies within the range, −VENC < |v⊥| <VENC
the pixel intensity in the phase difference image remains
linearly proportional to v⊥i, as indicated by Eqn. 3. Because
the phase difference reconstruction returns a value in the
range −π ≤Δϕi ≤ +π, VENC is related to the change in first
moment by:
VENC ¼ π
γΔm⊥
ð4Þ
v⊥i ¼ VENC Δϕi
π
ð5Þ
When |v⊥i| exceeds VENC, velocity aliasing will occur.
That means that velocities in excess of ± VENC will be
mapped (i.e., aliased) erroneously to velocities within the
range of ± VENC. Besides misrepresenting speed, flow-
related aliasing can also result in an artifactual reversal
of the displayed flow direction. Unfortunately, the alias-
ing velocity cannot be set arbitrarily high because that
incurs a signal-to-noise ratio (SNR) penalty. Provided
that |v⊥| <VENC, the SNR of the phase difference image
is given by
SNRΔϕ∝SNRM  v⊥VENC ð6Þ
where SNRM is the signal-to-noise ratio of the recon-
structed magnitude image. Notice that the phase SNR is
proportional to signal magnitude and velocity, but in-
versely proportional to VENC. A low VENC results in
higher phase SNR, however, if too low a value of VENC is
selected, unwanted flow-related aliasing occurs. Optimis-
ing an acquisition with low VENC setting may require
several acquisitions until the peak velocity is free of alias-
ing. It is possible to acquire images at multiple VENCs
within one breath-hold to assist this iterative optimization
(i.e., VENC Scout) but an acquisition at reduced spatial
and temporal resolution may miss some aliasing, though
aggressive scan-time acceleration may be used to alleviate
this [27]. In some cases, flow-related aliased images can be
salvaged with a post-processing technique called phase-
unwrapping [28–30]. Typically, however, some SNR is
intentionally sacrificed by selecting the value of VENC to
be sufficiently high to avoid aliasing in most patients, e.g.,
200 cm/s to measure healthy aortic flow. If resulting im-
ages still have unacceptable flow-related aliasing and
phase unwrapping methods are not available, the acquisi-
tion can be repeated with a higher value of VENC, as illus-
trated in Fig. 2.
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Fourier velocity encoding
In some cases, it is desirable to measure the distribution
of velocities within a pixel, rather than only the weighted
average. This can be accomplished with Fourier velocity
encoding [3], where the two flow encoding values men-
tioned earlier, A and B, are replaced by a longer series
(e.g., 8 or 16 values) of flow encoding steps separated by
constant increment of the first moment Δm1. The result-
ing data are then reconstructed with a discrete Fourier
transform instead of a phase difference method. At each
pixel, this procedure yields a set of images, each sensitive
to velocity within a specific range, or bin.
One advantage of Fourier velocity encoding is that by
examining the zero velocity image, we can measure the sta-
tionary tissue contribution to the signal for a particular
pixel. This is particularly useful at the boundary of the ves-
sel lumen, where pixels cover both flowing blood and sta-
tionary tissue. As discussed in more detail later, such partial
volume effects are a common source of systematic error
when using standard MR methods to quantify flow.
The main disadvantage of Fourier velocity encoding,
however, is that it increases the acquisition time by a
factor of N/2, where N is the number of velocity encod-
ing steps, compared to a standard phase contrast meas-
urement with 2 flow encoding steps. There have been
attempts at compensating by using faster acquisition
strategies [31, 32]. However, because of this acquisition
time penalty, Fourier velocity encoding has not been
widely used. Instead, as discussed later, the most popular
countermeasure against partial volume errors is simply
to increase the spatial resolution using standard velocity
mapping methods. Fourier velocity encoding, however,
has found application with 1D pencil beam excitation
imaging [33] (discussed further below), which is intrin-
sically fast.
Measuring the velocity vector
In some cases, it is desirable to measure the complete
velocity vector vi for each pixel i, rather than only its
perpendicular component v⊥i. Although this complete
vector measurement is not necessary to measure flow
through a vessel, it is required for other applications such
as tissue velocity mapping, as discussed later. Measure-
ment of the velocity vector requires a minimum of four
flow-encoded measurements [34], which we will label A,
B, C, D. Often A is acquired with flow compensation on
the slice selection and frequency encoding axes. This in-
volves adding gradient pulses that null the 0th and 1st mo-
ment of the gradient waveforms between excitation and
data collection. Then the first moment is changed by Δm1
on one axis at time for the B, C, and D acquisitions. For
example, we could set the first moment on the frequency
encoding axis to be Δm1 for encoding B; the first moment
on the phase encoding axis to be Δm1 for encoding C, and
similarly for the slice selection axis for encoding D. Using
acquisition A as a common phase reference, three inde-
pendent phase difference reconstructions and Eqn. 3
yields three separate velocity maps, each of which is sensi-
tized to flow in one orthogonal direction. Calling the three
velocity maps vxi, vyi and vzi, the vector velocity for pixel i
is given by vi¼ vxi; ; vyi; ; vzi
 
. If desired, a map of the flow
speed can be calculated from jvi j ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
v2xi þ v2yi þ v2zi
q
.
4D flow CMR
3D spatial encoding offers the possibility of isotropic
high spatial resolution and thus the ability to measure
and visualize the temporal evolution of complex flow
and motion patterns in a 3D volume, without any re-
strictions to predefined imaging planes. In this context,
ECG synchronized 3D phase contrast CMR (PC-CMR)
using 3-directional velocity encoding can be employed
to detect and visualize global and local blood flow char-
acteristics in targeted vascular regions [35, 36]. A num-
ber of recent methodological improvements permit the
accelerated acquisition of such data within scan times of
the order of 5-10 minutes. The number of potential ap-
plications of 4D flow CMR is growing, as covered by a
number of recent review articles [37–43].
Fig. 2 Difficulty where wraparound is not an “island” in the flow: a Peak flow through a mildly narrowed pulmonary vein showing velocity
aliasing of black into white (arrow) at VENC 80 cm/s. b Unwrapping this aliasing was uncertain in partial-volume pixels neighboring the reverse
flow channel (arrow) offset 50 cm/s. c The same plane acquired at VENC 130 cm/s showed true forward flow in black and the reverse flow
channel at its left on the image. (provided by Dr. Sylvia Chen, Royal Brompton Hospital, London, UK)
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Pulse sequence details and vendor acronyms
While often not stated explicitly, PC-CMR acquisitions
are generally RF-spoiled [44] to suppress multiple-TR sig-
nal pathways. In the absence of flow-induced intra-voxel
dephasing (discussed below), RF-spoiled magnitude im-
ages have mixed T1 and spin-density weighting, and some
T2* weighting depending on the TE. Several cycles of gra-
dient dephasing across the voxel is needed to suppress
ghost artifacts [45]. RF-spoiled 2DFT sequences have
vendor names such as spoiled gradient echo (SPGR), fast
low angle shot (FLASH), and T1-weighted fast field echo
(T1-FFE). Since the PC-CMR sequence is typically inter-
rupted at the end of each R-R interval while “waiting” for
the next ECG trigger, the corresponding sequence names
Fast SPGR, TurboFLASH, and TFE are sometimes used
instead. Spiral phase-contrast sequences are not widely
available, and in research papers are referred to as “spiral
SPGR” or simply “spiral”.
Artifacts and calibration procedures
PC-CMR is susceptible to unique artifacts that may alter
the qualitative visualization of flow, and introduce errors in
the quantification of flow volume or other hemodynamic
parameters. There is no single dominant source of error,
however several smaller errors may combine to result in
velocity or flow measurement errors on the order of 5 % to
10 % or more. The earliest work that validated PC-CMR
methods [46–48] included descriptions of these artifacts,
and more recent reviews can be found in [26, 49]. It is im-
portant to note that the relative importance of different
sources of artifact depends on the type of measurement be-
ing made, e.g., peak velocity or volume flow, and the type
of pulse sequence being used. This section specifically dis-
cusses artifacts in PC-CMR acquired with 2DFT gradient
echo pulse sequences.
Velocity signal and velocity noise
As suggested by Eqn. 6, reliably strong blood signal is
fundamental to PC-CMR. Exactly as in gradient-echo
cine imaging, in PC-CMR cine imaging, the longitudinal
magnetization of material in the slice is partially satu-
rated by the repeated RF pulses, more so for long T1s
such as blood. Inflow of unsaturated material into the
image plane or volume produces bright signal [50]. For
large volume imaging, there is little inflow often result-
ing in low steady-state signal, thus requiring the use of
low flip angles or T1-shortening contrast agents [51].
The total signal within a voxel may also be reduced or
entirely lost by dispersion caused by spatially non-
uniform, motion-induced phase shifts within the voxel,
also known as intra-voxel dephasing or intra-voxel phase
dispersion. This can be reduced by using flow compen-
sation, however, PC-CMR requires that at least one
flow-encoded image be obtained and by definition this
image cannot be flow-compensated. There is the poten-
tial for regions of weak blood signal in that image,
whereas the “reference” image can be fully velocity-
compensated, producing strong blood signal. The sub-
traction of the two phase images described by Eqn. 3 will
be unreliable if either image has low magnitude. The
noisy phase of a weak magnitude signal leads to errone-
ous pixels around jet flows, e.g., “edge spike” artifacts
[52] or “salt and pepper noise” [53]. Most systems offer
“balanced” or “symmetric” velocity encoding shared be-
tween the two images [54], which can reduce signal loss
due to intravoxel phase dispersion.
Signal can also be lost when there is turbulence or un-
steady motion on the timescale between excitation and
echo (a few milliseconds). In such cases, much of the
signal can be recovered by shorter duration of the gradi-
ent waveforms so that there is less time for incoherent
flow-related phase dispersion to occur [52, 53, 55], per-
haps ultimately using TE times on the order of 1 ms
[56]. The shorter gradient pulses do imply that stronger
gradient amplitudes are required, which partially coun-
teract the strong benefit of shorter TE [48]. Image post-
processing techniques can remove unreliable pixels [57],
but such methods require experienced supervision to
avoid unnecessary suppression of true velocity data. The
potential for high noise in individual pixel velocity mea-
surements is one of the reasons that peak velocity deter-
mination in stenoses should be made using several
pixels [53].
The problem of low velocity SNR can also be addressed
in post-processing using advanced denoising techniques.
Several such methods are based on the assumption of in-
compressible flow, which in turn dictates that flow fields
must be divergence-free. By fitting the measured velocity
field to a set of divergence-free “basis” functions [58] or
vector fields [59], a strictly divergence-free flow field with
reduced noise is obtained. Ong et al. [60] recently pro-
posed a related denoising technique that retains a non-
divergence-free flow component, which may arise due to,
e.g., partial volume and flow discretization. The problem
of suppressing noise while retaining physically meaningful
flow information is an active area of research.
Flow measurement will be impacted if the vessel bound-
ary region-of-interest (ROI) includes pixels whose signals
are only partially from flowing magnetization (“partial vol-
ume” effect). The consequence depends on the surround-
ing tissue signal strength compared to that of blood,
which is increased by fresh inflow enhancement. If the
blood magnitude is far brighter than the surrounding tis-
sue, and if the ROI includes the entire border pixel, then
there will be an over-estimation of the total flow. If the
two magnitudes are similar and the ROI again includes
the entire partial-volumed pixel, the total flow will be cor-
rect. However, given the image interpolation often applied,
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ROI software might not include the entire partial-
volumed raw pixel. In other words, the error due to
“partial volume” effects can depend on the implementa-
tion details of the ROI software as much as on the rela-
tive signal strength of blood and surrounding tissue.
The dependence of blood signal strength on fresh in-
flow confounds any general rule about setting ROI
drawing thresholds from magnitude images. Neverthe-
less, drawing ROIs on magnitude images is generally
found to be easier than drawing on velocity images.
Perhaps the most detailed study [61] concluded this dif-
ference was “almost negligible for clinical purposes” in
a great vessel model even with plug or skewed velocity
profiles causing high velocities and bright blood magni-
tude near the wall. In smaller vessels, to keep partial-
volume error below 10 %, at least 16 pixels should
cover the vessel [20, 21, 61]. Complex-difference pro-
cessing [62] and paraboloid fitting [63] reduce flow
measurement errors, but are subject to limitations such
as the assumption of laminar flow. In addition to these
considerations, it has recently been recognized that
partial volume from perivascular fat can cause chemical
shift-induced velocity measurement errors, which can
be minimized by imaging with high receiver bandwidth
and choosing the TE such that fat and (stationary)
blood signal are in-phase [64].
Image artifacts
Fluctuations in flow velocity during a 2DFT acquisition can
create ghosting artifacts along the phase-encoded direction
[65, 66]. This could be due to cardiac variability of flow-
related phase shifts in the raw data, which the image recon-
struction then assumes were made by the spatial phase-
encoding gradient pulses. Flow changes have been docu-
mented during large inspiratory breath-holds [67], end-
expiratory breath holds [68, 69], and during free breathing
[70, 71]. One common appearance is that of replication of
blood vessels along the phase-encoded direction. The sym-
metric velocity encoding approach can also weaken these
artifacts. Mis-triggering or variable delay in ECG-triggering
exacerbates such artifacts because it increases cardiac phase
variability between sections of raw data. Signal averaging in
non-breath-hold PC-CMR can reduce ghosting arising
from random and pseudo-random flow variability [72, 73].
The flow itself can also appear displaced, due to mo-
tion during the time differences between slice-
excitation, velocity-encoding, phase-encoding, and
frequency-encoding. These effects reduce with short
TE [48, 74, 75], but can still be significant in the case
of flow jets. For example, a 4 m/s post-stenotic jet
moves 12 mm in 3 ms, which by current standards
would be a short time between excitation and fre-
quency encoding. This would result in a displacement
of the visualized flow by up to 12 mm within the
reconstructed image. The exact location of the dis-
placed signal depends on the orientation of flow with
respect to the phase and frequency encoding gradients
[74], and may even end up outside of the vessel. Phase-
encode velocity compensation, if correctly imple-
mented, also reduces distortion of oblique flow [8, 76,
77], except for that due to acceleration [78].
Slice positioning near mobile cardiac valves especially for
regurgitation measurement has to balance multiple inaccur-
acies including distal Windkessel, coronary flow, proximal
valve motion and signal loss [79, 80], even if repeatability is
precise [81]. Prospective [82] and retrospective [83] valve-
plane tracking may offer improvements beyond what is cur-
rently available on commercial scanners.
Misalignment of the velocity-encoding gradient with re-
spect to the flow of interest results in an underestimation
of velocity by the cosine of the misalignment angle, as dis-
cussed previously. For peak velocity assessment, a “splayed”
jet emerging from a narrow or irregularly shaped orifice
may defy accurate velocity measurement [84]. Finally, trun-
cation or Gibbs artifacts can affect flow measurements, but
are most problematic only when there is another nearby
vessel [85].
Velocity errors
After the subtraction operation to form the phase differ-
ence image (Eqn. 3) there are residual contributions
to Δφi, notably those from gradient eddy current effects
[57], concomitant field (i.e., Maxwell) terms [86], and
gradient field distortions [87]. The residual phase errors
appear as a non-zero velocity in stationary tissue but
they affect the entire image often with gradual spatial
variation. If uncorrected, all three effects can signifi-
cantly distort the measured velocities and flow volumes
and can also result in distortion of 3D streamlines and
3D particle traces, described in the Flow Visualization
section. Such phase offset errors exhibit a substantial in-
crease with increasing distance from the isocenter of the
MR system, with the concomitant field and gradient field
distortion in particular varying super-linearly with dis-
tance. Even small systematic inaccuracies in measured
velocity can propagate into larger errors when comput-
ing volume flow. Its consequences and corrections are
reported in [88–90]. 2D PC-CMR measurements
performed in single vessel segments at or near the
isocenter of the magnet are relatively insensitive to these
errors. For 2D or 3D PC-CMR with large anatomic
coverage, however, correction is required. Increasing
interest in CMR phase contrast imaging to quantify
valvular heart lesions such as mitral regurgitation [91]
warrant re-examination of elements in clinical scan
protocols such as phantom scan or other approaches to
correct for phase offsets that remain problematic on
current-generation scanners.
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Corrections may be derived from stationary tissue
[57, 92], or derived from a stationary phantom ac-
quired with identical slice and pulse sequence parameters.
Alternatively, Giese et al. [93] recently demonstrated that
baseline PC offsets can be measured directly using mag-
netic field probes, which obviates the need for potentially
error-prone post-processing but requires specialized hard-
ware. Similar measurements by Busch et al. [94] showed
that PC offsets can vary significantly with the temperature
of the gradient coil mount, indicating the need for thermal
stabilization or dynamic offset correction. While back-
ground velocity offsets may be insignificant for peak vel-
ocity assessment, on some machines and protocols the
baseline offset becomes significant due to the area and tem-
poral summations used to calculate volume flows such as
cardiac output. Even small parameter changes such as slice
thickness or in-plane orientation may alter the offset, which
can arise from small errors in the eddy current correction
or the essential concomitant gradient correction [86]. Using
the smallest possible value of VENC or varying VENC
through the cardiac cycle [95] may reduce the offset error
in comparison to the velocity phase shift, but this is not al-
ways the case; for example, a smaller value VENC can pro-
voke a larger offset. Positioning the vessel of interest near
isocenter, or more realistically in the z = 0 plane, minimizes
the phase error from the concomitant field and generally
assists with many other aspects of scanner performance.
Furthermore, these background velocity offsets can be tem-
porally stable between cine frames conferred by cine im-
aging in breath-hold or free-breathing sequences [96],
which facilitates their identification and removal during
post-processing when the flows of interest are pulsatile.
However, large temporal variations can occur due to,
e.g., respiratory navigators in prospective cardiac gat-
ing sequences.
Impact of parallel imaging, high field systems, and
constrained reconstruction
PC-CMR requires multiple image acquisitions with differ-
ing first gradient moments, which can lead to long acquisi-
tion times. PC-CMR therefore particularly benefits from
acceleration via parallel imaging techniques, which rely on
receive coil arrays to reconstruct images from only a subset
of the complete k-space data. There are two “classic” paral-
lel imaging techniques that are supported by vendors:
sensitivity-encoded MRI (SENSE) and generalized autocali-
brating partially parallel acquisitions (GRAPPA). SENSE
[97] operates in image space, and is able to unwrap field-of-
view aliasing by combining images from a number of re-
ceiver coils once the sensitivity profiles of the coils have
been obtained. Therefore, SENSE reduces scan time by re-
ducing the acquired field-of-view. GRAPPA [98], on the
other hand, operates in k-space, and relies on the k-space
profiles of multiple receiver coils to fill the gaps between
sampled k-space lines. Both SENSE and GRAPPA are
phase-sensitive and can be used to accelerate PC-CMR,
and are supported by vendors. Note that the use of these
techniques in PC-CMR does not differ fundamentally from
their use in other applications.
The cost of speeding up image acquisition with SENSE
or GRAPPA is local image noise enhancement, which gen-
erally worsens with increasing acceleration (or “reduction”)
factor R, and improves with increasing number of receive
coils. The speed-up factor achievable with SENSE and
GRAPPA are comparable, and values of R = 2 to 3 have
been reported in 2D and 4D PC-CMR imaging at 1.5 T
[99–106]. Parallel imaging can also be combined with Car-
tesian or spiral EPI for real-time imaging [100, 107], for
which similar acceleration factors have been reported.
There are no strict criteria for setting the speed-up factor,
and it is ultimately up to the user to select an R that results
in acceptable noise and artifact levels for a given
application.
The trade-off between R and noise/artifact levels be-
comes more favorable at higher fields, since the image
SNR improves with increasing field strength, and be-
cause spatial coil sensitivity profiles become more inde-
pendent (localized). In addition, 3D spatial encoding is
particularly well-suited for parallel imaging since, for a
given net acceleration factor, “sharing” the undersam-
pling between the phase- and partition-encoding dimen-
sions can lead to improved image quality compared to a
2D acquisition. For these reasons one can generally ex-
pect 4D flow imaging at high field to enable the highest
speed-up factors [105, 106] [108–122]. Alternatively, for
a given reduction factor R, moving to higher fields can
produce smoother 3D flow streamlines, reduced noise-
induced measurement bias, and improved image SNR
which aids vessel segmentation [121].
Several groups have explored the possibility of speeding
up image acquisition further by combining parallel imaging
with advanced, often iterative and non-linear, con-
strained reconstructions that exploit spatio-temporal corre-
lations or sparsity [123–134]. These research methods go
under a variety of names, typically including keywords such
as “k-t”, compressed sensing, and spatio-temporal sparsity/
constraints/correlations. Spatio-temporal constraints can
also be combined with non-Cartesian undersampled PC-
CMR acquisitions such as 2D radial [135, 136], 3D radial
(“PC-VIPR”) [137], and 3D stack-of-stars [138]. The role
that these advanced acquisition and reconstruction
schemes may be able to play in routine clinical practice is
the subject of intense ongoing research.
Image analysis and flow visualization
By drawing an ROI around a vessel, basic statistics such
as average velocity (Eqn. 2), peak velocity, and a velocity
histogram can be determined. If ROI’s are drawn for
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each acquired time frame, one can determine flow as a
function of time over the cardiac cycle. By plotting the
flow values summed over pixels for each ROI at each time
point, flow rate versus time curves can be generated
(Figs. 3 and 4). The thermal noise (standard deviation) in
such ROI-averaged measures can be calculated from the
velocity SNR using the recently introduced approach by
Hansen et al. [139]. As discussed previously, care is usually
taken to trace boundaries near the edges of the vessel to
eliminate contamination from other vessels and to elimin-
ate errors in the integration due to inclusion of excess
static tissue [140]. These curves are used to determine
clinically relevant quantities such as aortic or pulmonary
regurgitant volume, abnormal ventricular filling patterns,
cardiac stroke volume (in mL/cardiac cycle), cardiac out-
put (in L/min), and quantification of flow in left-to-right
shunts [81, 141].
Time-resolved 2D PC-CMR pulse sequences with
through-plane velocity encoding are typically available on
all commercial MR systems. The resulting time-series of
magnitude images reflect the dynamics of the underlying
cardiac and/or vascular anatomy. The additionally calcu-
lated series of phase difference images represents the local
velocities along the flow-encoded direction with the same
spatial and temporal resolution as the anatomical data.
These images are typically visualized side-by-side using
gray-scale depiction of the measured blood flow velocities.
Alternatively, color-overlay similar to flow visualization on
Doppler echocardiography can be employed [142]. Pre-
senting the time-series of magnitude and phase difference
images in movie mode can depict the dynamics of the pul-
satile flow over the cardiac cycle.
The velocity field generated by CMR can be used to
determine other important physiologic parameters such
as pressure gradients, vessel compliance, and wall shear
stress (WSS), although these analyses are not yet available
commercially to our knowledge. Pressure gradients are an
indicator of the hemodynamic significance of lesions and
provide unique value over anatomy and velocity alone.
Pressure gradients can be determined by using the modi-
fied versions of the Navier-Stokes equations that depend
on the time and spatial velocity distribution in the flow
field [29, 143–145]. Note that CMR determines the spatial
gradient of pressure, not the absolute value of pressure.
The relative pressure maps generated from CMR can be
visualized as color-coded static images, or time-resolved
animations [145–147]. Wall shear stress, which is based
on evaluating the spatial gradient of the velocity distribu-
tion at the vessel wall, has been linked to endothelial cell
dysfunction and vascular remodeling [148] and the
Fig. 3 The left and right carotid arteries are outlined at each time frame on the phase or magnitude images using ROI’s (left). The instantaneous
flow rate values, Q(t) are determined at each time frame. The flow rate from each time frame is plotted versus time in the cardiac cycle to yield
flow curves (right)
Fig. 4 Flow versus time in the cardiac cycle for an ROI in the
ascending aorta of a patient with valvular regurgitation. The
negative flow in diastole is due to antegrade flow from the
regurgitation. Each point represents the integrated flow over the
ROI at one time point
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localization of atherosclerotic lesions, and can be esti-
mated reliably from 4D flow data [149–152] given suffi-
cient spatio-temporal resolution. Potters et al. recommend
at least 8 pixels across the lumen for accurate WSS esti-
mation, though this number may depend on the spatial
interpolation (fitting) method [153].
For the visualization of complex, three-directional
blood flow within a 3D volume, various visualization
tools including 2D vector-fields, 3D streamlines and
time-resolved 3D particle traces have been proposed
[154–156]. Since these visualization techniques have
been described in other reviews (e.g., [38]), here we
only briefly highlight their potential clinical importance.
Figure 5 illustrates whole-heart 3D flow visualization,
and shows that for a concentric aneurysm in the prox-
imal descending aorta, a relative flow acceleration in
the aortic arch developed into a flow pattern adapted to
the shape of the aneurysm, i.e., highly circulating flow
with a vortex core near the lateral wall [114]. Such al-
tered flow patterns may reveal impaired flow efficiency
or changes in hemodynamic parameters such as wall
shear stress.
II. Clinical applications
Valvular heart disease
Flow assessment in the patient with valvular heart dis-
ease (VHD) seeks to answer the following questions:
what is the severity of stenosis and/or regurgitation, and
what are the associated anatomic abnormalities? PC-
CMR may be called upon to answer these questions.
While transthoracic echocardiography is invariably the
first test chosen to assess flow in VHD, poor acoustic
window (even with contrast administration) and limita-
tions in acquisition plane may necessitate further testing.
The incremental utility of CMR for VHD must be demon-
strated in the context of other techniques such as trans-
esophageal echocardiography (TEE), a well-established
technique relied upon by surgeons to plan procedures such
as mitral valve repair. TEE, which may be done intraopera-
tive as well, readily demonstrates morphology and function
of the mitral valve apparatus and other valve structures and
function, albeit with risks associated with sedation and
esophageal intubation. CMR may be preferable when there
are contraindications to TEE, when other aspects of cardiac
structure and function uniquely assessed by CMR are needed
(e.g. viability), or when results from other more commonly
used modalities have yielded discrepant or inconclusive results.
Presence and severity of stenosis
One of two approaches may be used to determine sever-
ity of valvular stenosis with PC-CMR. The first is to seri-
ally obtain in-plane two-dimensional velocity-encoded
cine acquisitions to identify the direction of the peak
velocity, and then prescribe through-plane acquisitions
perpendicular to the jet direction to obtain the peak vel-
ocity. This works well when there is one predominant
stenotic jet (Figs. 6 and 7, Additional file 1A-D), but
fares less well in the setting of multiple jets. The other
approach involves velocity encoding in multiple direc-
tions over a volume that encompasses one or more sten-
otic jets emanating from the valve. This may not be
feasible due long acquisition times and limited availabil-
ity of post-processing tools to extract the peak velocity.
In practice, the former approach is most often used,
Fig. 5 Development of vortical flow patterns in the thoracic aorta in a patient with a tubular shaped aortic arch and an aneurysm of the proximal
descending aorta (yellow arrow, diameter = 4.2 cm). 3D streamlines within the 3D PC-MRA iso-surface illustrate accelerated flow along the outer
aneurysm wall (t = 180 ms) and subsequent formation of a flow vortex (t = 300 ms and t = 380 ms). Note that aneurysm formation affects blood
flow in the entire aorta resulting in marked helical flow in the ascending aorta (AAo, white arrows). From Ref. [107]
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recognizing that without meticulous prescriptions to
identify the plane of highest velocity one may easily
underestimate stenosis severity. Also, most current clin-
ical systems use segmented techniques that yield average
velocities over multiple cardiac cycles. Newer ap-
proaches to real-time velocity encoded cine imaging are
preferred when available to capture beat-to-beat vari-
ation [107, 142].
Stenosis severity by PC-CMR has shown good agree-
ment with Doppler measurements in the case of aortic
stenosis (AS) [157], and smaller studies suggest agree-
ment with catheter-derived pressure gradients [158]. In-
vasive pressure measurement across a severely stenotic
aortic valve confers considerable mortality risk, making
noninvasive estimation preferable. Further, imaging of
the aorta is essential given concomitant risk of ascending
aortic aneurysm that may also require repair at the time
of valve surgery. CMR is thus an ideal modality for
comprehensive assessment of aortic valve and associated
aortopathy.
Stenosis severity by PC-CMR in other valve lesions
has most commonly involved assessment of congenital
pulmonic stenosis and the right ventricular outflow tract
(RVOT), particularly in patients with repaired congenital
heart disease where distorted RVOT geometry benefits
from volumetric imaging. Mitral valve stenosis has also
been measured with PC-CMR, with both peak E velocity
and pressure half-time agreeing well with Doppler-echo
[159].
Presence and severity of regurgitation
Risk of sudden death and heart failure in regurgitant
valve lesions such as aortic valve insufficiency and mitral
regurgitation should prompt replacement or repair of
the valve when cardiac enlargement or dysfunction set
in – even in the absence of symptoms. The appeal of
Fig. 6 Aortic Stenosis. a Systolic frame from a balanced SSFP cine CMR acquisition in the left ventricular outflow tract plane shows a turbulent jet
emanating from a thickened aortic valve suggesting significant stenosis. b Short axis view at the level of the aortic valve demonstrates a bicuspid
valve en face with calcification of the anterior leaflet as well as at the commissural junctions. c Phase contrast image at mid-systole with VENC set-
ting of 250 cm/s shows extensive aliasing, suggesting the peak velocity is considerably higher than 2.5 m/s.
d Repeat phase contrast acquisition at the same location and point in the cardiac cycle with VENC increased to 450 cm/s eliminates aliasing,
allowing for accurate quantification of peak velocity across this stenotic valve. See also Additional file 1
Fig. 7 Aortic Stenosis (continued). a Quantification of phase-contrast data across the stenotic aortic valve shown in Fig. 6 indicates severe
stenosis, with peak velocity of 4 m/s. b Apical continuous-wave Doppler recording in the same patient underestimates stenosis severity (3 m/s)
due to misalignment relative to the direction of stenotic flow. c Invasive hemodynamics confirmed severe stenosis, with simultaneous aortic (Ao)
and left ventricular (LV) pressure measurement translating to an aortic valve area of 0.44 cm2/m2, with <0.5 cm2/m2 considered critical AS
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PC-CMR for measuring regurgitation severity lies in
the ability to directly measure flow across a valve, e.g.,
regurgitant volume, instead of secondary estimates of
severity such as vena contracta or proximal isovelocity
surface area that are used in echocardiography. As
such, PC-CMR holds particular utility when precise,
serial assessment of regurgitant volume as well as ven-
tricular response to volume overload is needed to
guide timing of intervention. Regurgitation across
semilunar valves is relatively straightforward in acqui-
sition, with care taken to avoid errors due to through-
plane motion of the valve plane and background phase
shifts. Echocardiographers’ ratings of aortic regurgita-
tion severity shows considerable overlap with CMR
quantification of regurgitant fraction [160], underscor-
ing the utility of the PC-CMR approach when distin-
guishing among AR grades of severity affects decision-
making. Li and colleagues showed reasonable agree-
ment between echo-Doppler and PC-CMR estimates of
regurgitation severity in patients with repaired tetral-
ogy of Fallot (TOF) [161]. As reviewed in the Congeni-
tal Heart Disease section below, PR quantification is an
integral part of the assessment of complex post-TOF
repair cardiovascular structure and function.
Measuring regurgitant volume across atrioventricular
valves may require alternate means of estimation given
the non-planar geometry of the regurgitant orifice and
the often-eccentric jet directions (Figs. 8 and 9,
Additional file 2). Hundley and colleagues showed that
subtraction of the forward aortic stroke volume by
PC-CMR from the LV stroke volume by cine CMR
yielded a mitral regurgitant fraction that agreed well
with angiographic estimates [162]. A recent review
provided the following classification of mitral regurgi-
tation severity as: mild = RF ≤ 15 %, moderate = RF
16–24 %, moderate-severe = RF 25–42 %, severe = RF
>42 %, but also underscored the complementary utility
of visually assessing MR jets on multi-slice SSFP cine
imaging [80].
Congenital heart disease
Thorough interrogation of structure and function in
congenital heart disease (CHD) with CMR invariably re-
quires flow measurement. As with VHD, Doppler-
echocardiography remains widely used to detect and
measure velocities and flow in CHD. Unlike VHD, how-
ever, PC-CMR may be the sole modality used in centers
where expertise in congenital CMR examination affords
consistent and reliable assessment of complex cardiac
and vascular anatomy and hemodynamics. As detailed
below, PC-CMR is an integral part of the CMR examin-
ation across a wide range of CHD lesions from simple
defects to complex cyanotic heart disease.
Presence and severity of shunts
A variety of congenital abnormalities may lead to inappro-
priate transfer of blood from one side of the circulation to
the other. This shunting typically occurs from the higher
pressure left-sided to the lower pressure right-sided circula-
tion, though right-to-left or bidirectional shunting may
occur. The most common form of intracardiac shunt is
atrial septal defect (ASD), which may produce heart failure
and pulmonary hypertension due to volume overload of the
right heart, with or without concomitant anomalous pul-
monary venous drainage or other anomalies. ASD evalu-
ation requires defining the presence, location, and size of
the defect and surrounding rims of tissue. ASD evaluation
also requires computation of the pulmonary to systemic
flow ratio (Qp:Qs), for which PC-CMR is ideally suited.
This is typically done by computing ratio of through-plane
flow across the main pulmonary artery to through-plane
flow through the proximal aortic root. A similar acquisition
is used for both measurements. The time delay between
these two scans is minimized in order to avoid significant
changes in cardiac output between measurements. In a
group of adults with ASD and other shunts referred for in-
vasive hemodynamic evaluation, Hundley et al. validated
Qp:Qs by PC-CMR against invasive oximetry and indicator
dilution, showing good agreement in shunt fraction [163].
Fig. 8 Mitral Regurgitation. a Late post-gadolinium enhancement imaging in a patient with dyspnea demonstrates extensive infarct scar of the
inferior and lateral walls (arrows). b Systolic frame from a three-chamber cine SSFP acquisition shows dephasing due to turbulent mitral
regurgitation flow back into the left atrium. c In-plane velocity-encoded cine frame in systole also demonstrates the mitral regurgitation jet
(arrow), but more clearly demonstrates its eccentric direction. The jet reaches back to the pulmonary vein ostia, consistent with
severe insufficiency
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A similar comparison was made more recently by Debl
et al. [164]. Beerbaum et al. extended this comparison
to a large group of pediatric patients, confirming ac-
curacy of Qp:Qs in both patients with as well as those
without ASD [165]. This work did not find through-
plane flow quantification directly across the defect as
reliable, though Thomson et al. were able to do this
successfully but only with meticulous, sequential ac-
quisitions to obtain the ideal plane for en face ASD
flow measurement [166].
Ventricular septal defects (VSDs) often occur in con-
junction with other congenital defects such as tetralogy of
Fallot or as part of atrioventricular septal defects. When
PC-CMR is called upon to evaluate a VSD, it is usually in
the context of complex anatomy beyond the simple mus-
cular, restrictive VSD that produces no hemodynamic ef-
fect. As with ASDs, Qp:Qs measurement with PC-CMR
that can be compared to short axis cine-derived left and
right ventricular stroke volumes [167] provides a useful
parameter for clinical management.
Other causes of shunt flow include anomalous pulmon-
ary venous drainage [168], patent ductus arteriosus
(Fig. 10, Additional file 3), aortopulmonary collaterals
(APCs) [169] and iatrogenic shunts, such as those used to
palliate cyanotic heart disease. Reliance on Qp:Qs to de-
tect and quantify shunt flow should occur in the setting of
several caveats. First, advanced pulmonary hypertension
may blunt left-to-right shunting (Eisenmenger physi-
ology), particularly in the presence of a large, long-
standing intracardiac defect (Fig. 11, Additional file 4).
Small shunts such as those seen with intermittent flow
across a patent foramen ovale may not produce significant
changes from normal in Qp:Qs, and borderline abnormal
Qp:Qs results should prompt a search for other evidence
before inferring presence of a shunt.
Other congenital heart disease applications
Interrogation of branch pulmonary arteries for stenosis is
an important part of the CMR examination in patients
with repaired TOF. In-plane PC-CMR prescribed along
the right and left pulmonary arteries can demonstrate tur-
bulent flow and jet direction, through which perpendicu-
lar through-plane PC-CMR can be used to obtain peak
velocities beyond sites of vessel narrowing that may result
from prior palliative surgeries. Similarly, both in-plane
PC-CMR in an RVOT view followed by appropriately-
Fig. 9 Mitral Regurgitation (continued). Quantification of mitral regurgitant volume in the case shown in Fig. 8 was done by subtracting the
forward stroke volume across the aortic valve by PC-CMR from the total LV stroke volume. LV stroke volume is computed by using any of a
number commercially-available software packaged (Argus, Siemens shown) to delineate endocardial borders at end-systole and end-diastole in
each of the contiguous short axis cine CMR planes covering the length of the LV. The difference in volumes computed using Simpson’s rule is
the LV stroke volume. In this patient, the mitral regurgitant volume was 100 (LV stroke volume by cine CMR) – 45 (aortic stroke volume by PC
-CMR) = 55 mL, or a regurgitant fraction of 55 % consistent with severe mitral regurgitation
Fig. 10 Patent Ductus Arteriosus. a Contrast-enhanced magnetic
resonance angiogram in the sagittal plane demonstrates a patent
ductus arteriosus (PDA, arrow) communicating between the
proximal descending aorta (Ao) and pulmonary artery (PA). b
In-plane PC-CMR shows flow from the aorta into the PA via the PDA
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prescribed through-plane PC-CMR acquisitions yield use-
ful qualitative and quantitative information. Distinguishing
valvar from subvalvar or supravalvar pulmonic stenosis
benefits from this approach, dictating distinct approaches
to management. Imaging of the aorta is a central applica-
tion of CMR in congenital heart disease, and PC-CMR
provides complementary information on location and se-
verity of, for instance, aortic coarctation [170].
Flow assessment in CMR examinations
While ‘routine CMR examination’ is something of a mis-
nomer, it is worth asking when phase contrast acquisition
is required if a priori clinical information does not indicate
a specific valvular or congenital lesion requiring flow as-
sessment. In patients referred for myocardial viability as-
sessment, for instance, detection of presence and severity of
mitral regurgitation may be helpful in surgical planning
Fig. 11 Ventricular Septal Defect. End-diastolic (a) and end-systolic (b) frames of a horizontal long-axis cine CMR acquisition demonstrate a large
ventricular septal defect (VSD) of the basal half of the interventricular septum. In-plane PC-CMR showed no appreciable flow across this
long-standing, restrictive VSD (Additional file 4). Through-plane PC-CMR with regions of interest (dotted circles) encircling the aortic valve
(c,d) and pulmonic valve (e,f) allowed calculation of Qp:Qs that yielded a value close to 1:1, consistent with Eisenmenger physiology or advanced
pulmonary hypertension limiting flow across even a large defect
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given increased postoperative mortality in patients with sig-
nificant MR whose valve disease is not addressed at the
time of bypass surgery [171]. Given the increased sensitivity
of PC-CMR to flow disturbances compared to cine im-
aging, especially short TR balanced SSFP techniques, it is
reasonable to include through-plane PC-CMR at the level
of mitral leaflet coaptation to screen for ischemic MR in pa-
tients referred for CMR to assess viability. In patients with
right heart dysfunction of unknown etiology, screening for
intracardiac shunt with first-pass perfusion imaging as well
as through-plane aortic and pulmonic flow quantifications
allows for estimation of Qp:Qs, with the limitations cited
above in shunt detection with this approach. Finally,
PC-CMR can be used to assess LV diastolic function,
using a combination of mitral through-plane flow quan-
tification and low-VENC acquisition to measure tissue
velocities [172]; this combination forms a useful ad-
junct in comprehensive CMR examination of the pa-
tient with heart failure [172, 173].
III. Emerging applications
Coronary artery flow imaging
Assessment of coronary artery flow is challenging due
to the small size, tortuous path, and cardiac and re-
spiratory motion of the vessels. PC-CMR coronary flow
measurements are either done with breath-holding
[120, 174–177] or during free breathing [175, 177–
179] with the navigator echo gating technique. Breath-
holding approaches have the advantage of being fast
and easy to implement, but typically provide lower
spatial (>1 × 1 mm) and/or temporal (~80-100 ms)
resolution than navigator gated techniques. Low tem-
poral resolution can lead to motion blur [177], which
can be especially apparent in the right coronary artery
(RCA) [180] due to its extensive motion in end systole
and atrial contraction. In addition, breath-hold mea-
surements suffer from reduced filling of the ventricles
leading to a reduction in coronary artery flow and
heart rate [67]. In contrast, free breathing approaches
do not affect patients’ hemodynamics and allow for sub
millimeter spatial resolution and increased temporal
resolution (~20-40 ms) [175, 177, 178] resulting in im-
proved accuracy of flow quantification [175]. Irregular
breathing patterns and diaphragmatic drift can prolong
scan time and may lead to motion artifacts.
Various acquisition techniques have been employed for
phase contrast coronary flow imaging including seg-
mented fast gradient echo (2DFT) [47, 174–178], echo
planar (EPI) [181], and spiral [120, 178, 182, 183]. Both
EPI and spiral acquisitions allow for increased temporal
resolution (~20-25 ms) while spiral data sampling also
provides increased SNR, which can be traded for in-
creased spatial resolution (0.8 × 0.8 mm) [183]. EPI only
provides moderate spatial resolution (1.6 × 1.6 mm) [181].
PC-CMR coronary flow imaging has been validated
against ultrasound [184, 185], Doppler flow wire [175,
179, 186] and positron emission tomography (PET)
[187] measurements in animals and humans both dur-
ing rest and during hyperemic stress demonstrating rea-
sonably good correlation (r = 0.7 – 0.9) between those
techniques. Coronary flow reserve measurements during
hyperemic stress have shown useful for the detection of the
functional significance of coronary artery stenoses and
demonstrated good sensitivity and specificity for the differ-
entiation between normal coronary segments, and seg-
ments with <75 % and >75 % luminal stenoses [179, 188].
The combined measurement of coronary sinus flow and left
ventricular (LV) mass allows assessment of total myocardial
flow in mL/g/min as well as average coronary blood flow
[189]. Validation studies with an ultrasonic volumetric flow
meter in dogs showed good correlation between coronary
sinus blood flow by PC-CMR and total coronary blood flow
by flow meter (r = 0.98, p < 0.001) [190]. Schwitter et al.
demonstrated good agreement between total myocardial
blood flow measured by PC-CMR coronary sinus flow
(divided by LV mass) and [184] N ammonia PET in
healthy subjects (0.73+/-0.15 mL/g/min vs. 0.77
+/-0.19 mL/g/min, r = 0.95) [187]. The clinical usefulness
of this technique has been demonstrated in patients with
diffuse myocardial disease such as hypertrophic cardiomy-
opathy [191] and in cardiac transplantation [187]. Kawada
et al. investigated 29 patients with hypertrophic cardiomy-
opathy during rest and hyperemic stress [191]. Patients with
hypertrophic cardiomyopathy had significantly lower myo-
cardial blood flow during dipyridamole stress compared to
healthy subjects (1.03+/-0.40 mL/g/min vs. 2.14
+/-0.51 mL/g/min, p < 0.01). Schwitter et al. found similar
results in transplant patients [187]. Coronary flow reserve
was reduced in patients with transplanted hearts compared
to healthy subjects (2.0+/-0.4 vs. 3.9+/-1.4, p < 0.005).
Coronary flow measurements used in concert with cor-
onary magnetic resonance angiography, vessel wall im-
aging and assessment of coronary endothelial function
may allow for comprehensive non-invasive assessment of
coronary artery disease.
Pulse wave velocity and vessel compliance
By making measurements at different locations along
a blood vessel, PC-CMR can be used to quantify the
velocity of the pulse wave generated by the ejection
of blood from the left ventricle and, consequently,
blood vessel compliance. The relationship between
pulse wave velocity and compliance is given by
C ¼ 1
c2ρ
ð7Þ
where C is compliance, c is pulse wave velocity, and ρ is
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blood mass density. With the assumption of constant
blood mass density, measurement of pulse wave velocity
completely determines vessel wall compliance.
Structurally, vessel compliance is determined by the tis-
sue components that comprise the blood vessel wall, in-
cluding the endothelium, elastin, and collagen, and on their
various amounts and interconnections. In vascular disease
the various components and interconnections undergo
changes and vessel compliance decreases. Decreased com-
pliance of the aorta in particular is associated with in-
creased risk of the progression of cardiovascular diseases
such as atherosclerosis and hypertension [192]. The meas-
urement of aortic compliance may be important in these
patients and also in patients with aortic aneurysm and dis-
section [193].
At least three variations on velocity-encoded CMR have
been developed for imaging pulse wave velocity. For the
first method, imaging is performed in a plane that is per-
pendicular to the blood vessel, images are acquired at (at
least) two different spatial locations, and velocity encoding
is applied in the through-plane direction [194]. If the vessel
being assessed is the aorta, then a single slice positioned su-
perior to the aortic valve can simultaneously intersect both
the ascending and descending aorta. For each slice, blood
flow is plotted versus time and the time corresponding to
the end of the foot of the flow-time curve is identified (such
as for three locations as shown in Fig. 12c). If Δt is the dif-
ference in the time to the onset of flow for two slices and D
is the distance along the centerline of the vessel between
the two slices, then the pulse wave velocity (PWV) is
PWV¼ D
Δt
ð8Þ
Since PWV is typically 4 – 10 m/sec in the aorta, phase
contrast images must be acquired with a temporal reso-
lution of around 10 ms to resolve differences in the time to
the onset of flow at different slice locations. This approach
has been used in a number of clinical research studies to in-
vestigate aortic compliance in aging [194], type 2 diabetes
[195], cancer survivors exposed to anthracycline treatment
[196], and in juvenile idiopathic arthritis [197].
Fig. 12 Fourier-velocity-encoded M-mode pulse sequence and pulse wave velocity data. a Scout image with position of M-mode pencil denoted
as line. b ECG-gated M-mode pulse sequence, with pencil excitation (box) and Fourier velocity encoding is acquired typically over 64 heartbeats.
c Three out of 256 velocity-vs-time waveforms generated along the length of the pencil. Green lines denote best fits to the foot of each
waveform. The time of the foot (yellow arrow) is plotted against position in (d). The inverse slope of the best-fit line to the point yields the pulse
wave velocity (provided by Dr. Chris Hardy, GE Global Research Center, Niskayuna, NY)
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Another variation on this basic method that has been ap-
plied to the aorta is to use an oblique sagittal plane that in-
cludes the axis of the vessel [198, 199]. Using this method,
velocity-encoding is applied in the two orthogonal in-plane
directions, rather than in the single through-plane direc-
tion. Then, the time of the onset of axial velocity (velocity
down the length of the blood vessel) can be plotted versus
longitudinal position along the vessel, and the slope of this
line yields the pulse wave velocity. The advantage of this
technique is that more points are used to estimate the
slope, perhaps leading to better accuracy. The disadvantage
of this method is that it only applies to vessels where a sin-
gle plane can intersect the vessel over a fairly long distance.
A third method for imaging pulse wave velocity in the
aorta is to use a cylindrical or “pencil-beam” radiofre-
quency excitation with Fourier velocity encoding [33].
This method, which is similar to M-mode echocardiog-
raphy, is illustrated in Fig. 12. This technique employs a
gradient for Fourier-spatial encoding of the signal along
one spatial direction (the length of the aorta), and a range
of velocity-encoding bipolar gradients for Fourier velocity-
encoding of the signal. Two-dimensional Fourier trans-
formation then provides velocity profiles as a function of
position along the blood vessel. Because the data are not
phase encoded, data acquisition is rapid compared to 2D
imaging, and high temporal resolution is feasible. Once vel-
ocity profiles are measured as a function of position, pulse
wave velocity is computed in a manner similar to the other
techniques.
Flow imaging to determine boundary conditions for CFD
simulation
Although PC-CMR can provide reasonable and satisfac-
tory representations of the velocity field in regions with
relatively slow variations of the spatio-temporal distribu-
tion of velocities, conventional MR velocimetry is lim-
ited in regions where there are pronounced changes in
velocity within a voxel. This is generally the case close to
the vessel wall where there is a steep, and unknown, gra-
dient of velocities – both in time and space [200]. It is
precisely this gradient of velocities that determines the
wall shear stress, the force that an individual endothelial
cell experiences, and that modulates the response of the
vessel wall to hemodynamic forces.
Computational fluid dynamics (CFD) has emerged as
an important tool for estimation of hemodynamic de-
scriptors that could be key indicators of the evolution of
vascular disease beyond what is currently available with
any non-invasive imaging method [148, 201–203]. The
methodology for describing physiologically realistic
intravascular flow has made rapid advances, enabled by
the available computational platforms and dedicated
software packages. CFD can estimate velocity fields in
tortuous vessels carrying pulsatile flow with spatial and
temporal resolution that is far beyond what is possible
with current MR imaging approaches [204].
The governing equations that describe the flow of fluid
through a prescribed geometry are the Navier-Stokes
equations. Numerically solving these equations using CFD
models yields the velocity field. In general, although more
general approaches have been pursued, analysis of flow in
vascular structures is performed with two simplifying as-
sumptions, namely that blood can be considered to be
Newtonian and that the vessel walls are rigid. Although
CFD methods have been used in application to idealized
representations of vascular geometry, their greatest value
comes in the calculation of velocity fields on a patient-
specific basis [202, 205, 206]. In order to achieve this
goal, the CFD model requires accurate boundary con-
ditions [207]. For a vascular segment of interest, the
required boundary conditions are both geometric,
namely a full description of the luminal surface over
that segment, and physiologic, describing all time-
varying flow contributions into and out of the segment
of interest. CMR is the radiologic imaging modality
that is best suited for defining the boundary condi-
tions. There are a variety of MRA methods for delin-
eating the vascular lumen, including time-of-flight
MRA, contrast-enhanced MRA, and phase contrast
MRA [208]. Although other modalities such as Rota-
tional Catheter Angiography, or Multi-Detector CTA
have better spatial resolution than these MR angio-
graphic methods [209], MR is the only modality that
can, in addition, provide the profile of flow velocities
across the flow lumen through the cardiac cycle. Al-
though Doppler Ultrasound has unmatched spatial and
temporal resolution, it is not able to simultaneously
detect for example transverse velocity components at
the same time as axial velocity components, which
limits its ability to estimate the velocity profile across
the vessel lumen [210].
The importance of having an accurate estimate of
the inlet flow conditions is illustrated in Fig. 13. This
figure depicts the velocity fields calculated for a
patient-specific geometry of an individual with a giant
fusiform basilar artery aneurysm that receives flow
from the two proximal vertebral arteries. The velocity
field calculated for this specific geometry is shown for
different assumptions on the relative flow contribu-
tions from each vertebral artery with the center image
depicting equal inlet flow. It is clear that the calculated
velocity fields and any derived quantity, such as WSS,
vary substantially depending on the relative flow con-
tributions from each inlet vessel.
The MR velocimetry method most often used for meas-
uring the inlet flow velocities is two-dimensional PC-CMR
applied to a slice transverse to the inlet vessel of interest
[211]. If there are multiple inlet vessels, as is the case for
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evaluation of the velocity field in the basilar artery where
both vertebral arteries serve as inlet vessels, it is then neces-
sary to measure the flow in each vessel. Alternatively, 4D
flow CMR provides a powerful approach to defining the
velocities in all relevant inlet vessels that does not require
the separate acquisition of velocity waveforms in each of
the inlet vessels [212]. The 4D velocity data can be post-
processed to determine the velocity distributions across
cross-sections transverse to each of the inlet vessels and
those values will then serve as boundary conditions to the
CFD calculation.
In CFD, prescribing the velocity profiles across both
the inlet and the outlet vessels may over-determine the
system and, to the extent that the flow waveforms might
be different, would present a problem that is insoluble
due to violation of continuity in the domain. Rather than
prescribing velocity values at the outlets, pressure values
in each outlet can be set. The pressure values prescribed
at the outlets define how the flow will split among the
distal vessels. Another option is to specify zero stream-
wise velocity gradients at the outlets. In some recent
studies, outlet boundary conditions were obtained by
linking a relatively simple, general model of the down-
stream circulation to a three-dimensional, patient-
specific model [213].
In principle, the complete prescription of the inlet vel-
ocity boundary conditions needed for CFD requires a de-
tailed determination of all three components of the
velocity vector in each pixel across the vascular lumen. Al-
though this is possible, that determination comes at the
cost of temporal resolution, as echoes that would other-
wise provide unique points through the cardiac cycle are
used to determine each additional velocity vector compo-
nent. Another approach uses PC-CMR to determine the
total flow through the vessel whereby only the component
of the velocity vector that is perpendicular to the imaging
slice is encoded. A CFD model is then constructed of the
vascular geometry including inlet vessel segments prox-
imal to the slice where the velocity was measured. The
measured flow waveform is used as the inlet value at this
more proximal location and a parabolic profile of veloci-
ties is assumed across the lumen. With this approach, the
correct volume flow waveform is retained and the distri-
bution of velocity vectors across the flow lumen reflects
the simulated impact of the tortuosity of the proximal ves-
sel segment.
Although CFD methods have the advantages that have
been described above, namely that they are able to provide
data sets with very fine resolution, important refinements
are needed to correctly describe more advanced situations.
Fig. 13 Giant fusiform basilar aneurysm: geometric and flow boundary conditions, and CFD predicted velocity fields for three different flow
conditions. a Geometric boundaries as defined by Contrast-Enhanced MRA, b Flow boundary conditions from a slice transverse to a vertebral
artery. c Velocity field with a high ratio of flow in the right vertebral artery relative to that in the left; d Velocity field with equal flow in each
vertebral artery; and e Velocity field with a low ratio of flow in the right vertebral artery relative to that in the left
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These include: intermittent or turbulent flow which can
occur in cases such as atherosclerotic stenoses or valvular
dysfunction [214]; compliant vessel walls which pulsate
through the cardiac cycle [215]; and inclusion of non-
Newtonian viscosity descriptions for cases of slow recircu-
lating flow [216]. Modifications of the standard CFD
approach have been proposed for each of these cases: dir-
ect numerical simulations (DNS) requiring numerically in-
tensive computations can account for turbulence [217];
fluid-structure interaction (FSI) approaches are being in-
creasingly used to describe compliant vessels [218]; and
there are a variety of non-Newtonian viscosity models that
have been proposed [219]. These situations provide an
intriguing opportunity for high resolution, multi-
dimensional PC-CMR methods, offering the potential that
these in vivo measurements could serve as a reference
standard for validation of CFD approaches. The interplay
of direct PC-CMR methods and numerical CFD ap-
proaches promises to be an interesting area of continued
investigation.
Tissue velocity mapping
Assessment of myocardial motion is central to the clinical
evaluation of ischemia and myocardial viability. Tissue
Doppler echocardiography has became an important mo-
dality for disorders involving cardiac wall motion [220],
but is limited in its ability to provide reproducible and
complete 3D motion estimates. CMR-based tissue tagging
[221, 222] allows direct visualization of wall motion but
has limited spatial resolution and requires relatively com-
plex post-processing. PC-CMR is a potential alternative to
these techniques, and offers 3D motion imaging with high
spatial resolution and high reproducibility.
The application of PC-CMR to tissue velocity mapping
(TVM) is in principle straightforward, however a relatively
low VENC (< 5 cm/sec) is required for adequate velocity
SNR. Large bipolar gradients are therefore required, which
may make the need for accurate velocity offset correction
particularly important in PC-based wall motion imaging.
Another complication is image artifacts from flowing blood,
which are also exacerbated by the low VENC. These arti-
facts can be suppressed using spatial presaturation (black-
blood) techniques [223, 224].
Conventional 2D acquisitions [225] for myocardial
phase contrast to represent the 3D structure of the heart
suffer from variable (non-isotropic) spatial resolution and
potential misregistration due to different long axis and
short axis acquisitions typically used to obtain a full set of
data. To overcome this, 4D velocity mapping can be ap-
plied in the same manner as in conventional PC-CMR
[35, 226, 227]. Alternatively, a hybrid approach that com-
bines phase contrast imaging for through-plane motion
with in-plane tagging can be used to derive 3D myocardial
motion [228]. To improve temporal and/or spatial
resolution, the same speed-up techniques discussed previ-
ously can in principle be applied to tissue velocity map-
ping, including, e.g., view-sharing [25], spatio-temporal
parallel imaging [125], and rapid acquisition strategies
such as spiral [229].
While the acquisition technology for phase-contrast
TVM can be considered mature, at least in the sense that
it tracks the development of conventional PC-CMR
methods, the task of estimating regional strain and motion
from PC-CMR data remains an active area of research. A
variety of analysis methods have been proposed, and ra-
ther than offering specific guidelines for PC-CMR TVM
analysis we only provide a brief summary of suggested ap-
proaches, and of several validation studies. Among the
proposed analysis methods are motion tracking and ‘glyph’
visualization methods with reduced sensitivity to errors
due to noise and other sources [230, 231], and limited
temporal resolution [232]. The 2008 paper by Haraldsson
followed work from the same group defining a method for
calculation of a time resolved strain rate tensor [233]. The
Pelc group developed a number of methods for data ana-
lysis, validation, and pulse sequence design [234–237], in-
cluding introduction of a closed form integration method
for calculating motion trajectories from phase contrast data
[238], 3D motion tracking [239], and analysis of the effects
of artifacts on myocardial velocities due to flowing blood
[223]. Related methods include an iterative optimization
method to compute time resolved velocity maps in the
myocardium [240], and an approach for Fourier tracking
on time-resolved 3D phase contrast data to track ‘virtual’
markers in the myocardium [241]. The task of estimating
regional strain and motion from PC-CMR data remains an
active area of research.
A number of studies have been performed in healthy vol-
unteers comparing strain measurements derived from PC-
CMR to other methods previously published [172, 242]
[243, 244], and to determine normative data from
which to compare patients with cardiac abnormalities
[245–247]. PC-based measures have been validated
against tissue-Doppler ultrasound [172, 242] and inva-
sive measurements [172], showing good agreement.
Motion derived by phase contrast CMR has also been vali-
dated against visual inspection of signal voids caused by
implanted markers [243]. Normal values of myocardial
velocity were obtained by Petersen et al. in 96 healthy
volunteers [245], using the black-blood approach of
Hennig et al. Figure 14 shows typical myocardial vel-
ocity values. Age differences have also been observed.
Foell et al. [246, 247] studied high temporal resolution
myocardial velocities in different age groups in healthy
volunteers and found differences in peak velocity and also
in the temporal evolution of velocities across age groups.
The potential clinical usefulness of PC-CMR tissue vel-
ocity mapping has been demonstrated in several animal
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and human studies. Comparisons between healthy volun-
teers and patients include a study of long axis motion of
the heart showing reduced velocities and delayed relaxation
in patients [225, 248], and the work by Markl et al. [249]
showing localized wall motion deficits in patients with
myocardial infarction. Ischemia has been shown to cause
alterations in velocity gradients in dogs [250]. Nahrendorf
applied PC-CMR in addition to perfusion imaging in
knockout mice, demonstrating that abnormalities in creat-
ine kinase-deficient mice can be detected [251]. They also
demonstrated in a separate study [252] that 3D myocardial
motion could be obtained using phase contrast imaging at
a field strength of 17.6 T in mice, following up earlier work
published in 2003 [253]. Dicks et al. [254] showed the effect
of coronary microembolism in a pig model on myocardial
strain and compared to delayed enhancement imaging. The
strain in the area at risk as determined by perfusion im-
aging did not differ from strain in the remote myocardium.
Strain in the area of patchy microinfarction declined over a
week post-infarction, providing a method of assessing lon-
gitudinal changes in myocardial function.
There have been a number of other applications of
phase contrast imaging of the myocardium as well. Phase
contrast sequences have been used as input to biomech-
anical models of the heart as shown for example by Liu
[255]. Lee et al. also used phase contrast myocardial data
to validate myocardial contractility modeling [256]. There
have also been a number of studies using myocardial vel-
ocity as an aid to segmentation of the left ventricle [257].
Displacement ENcoding with Stimulated Echoes
(DENSE) CMR is another technique to quantify myocar-
dial motion, where phase contrast images are recon-
structed and in which the signal phase is encoded for
tissue displacement, as opposed to tissue velocity [258].
This is accomplished with the use of stimulated echoes,
in which a component of the transverse magnetization is
stored as longitudinal magnetization during an adjust-
able “mixing” period [259], and then refocused with a
gradient lobe. While spins in both stationary and dis-
placed tissue are fully refocused to form a stimulated
echo, the phase of the echo (i.e., the acquired signal) will
be different for stationary and displaced tissue. There-
fore, the phase contrast between images acquired before
and after the mixing period is directly proportional to
the net tissue displacement that occurred during the
mixing period. Although the use of stimulated echoes
increases scan time compared to a velocity-encoded ac-
quisition, DENSE greatly simplifies the strain calculation
task. In addition, background velocity offsets are gener-
ally reduced in DENSE since identical displacement-
encoding gradients are used for both images (for a given
displacement-encoding direction). Compared to CMR
Fig. 14 Myocardial velocity from 96 volunteers in radial, circumferential, and longitudinal directions at 3 short axis locations in the heart,
normalized to the cardiac cycle length. (Reprinted with permission from Ref. [227])
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tagging, DENSE offers higher sensitivity and spatial reso-
lution and is becoming a popular technique for myocar-
dial motion imaging.
Summary
In summary, PC-CMR techniques for the measurement
of velocity continue to improve through advances in
equipment, pulse sequences, post-processing techniques,
and visualization software. There are a number of clin-
ical applications that use PC-CMR, most notably the
evaluation of valvular diseases and flow in patients with
congenital heart defects. Newer applications such as cor-
onary artery flow measurement, tissue velocity mapping,
and pulse wave velocity determination, and new meth-
odologies such as CFD and 3D visualization, will ensure
that PC-CMR techniques will expand their role in clin-
ical and research applications.
Additional files
Additional file 1: Aortic Stenosis. A. SSFP cine in the LVOT plane
demonstrates the turbulent jet of aortic stenosis. B. Small field of view
cine shows a bicuspid aortic valve en face with calcification. C.
PC-CMR acquisition at VENC setting of 250 cm/s shows aliasing that is
eliminated by increasing the VENC setting to 450 cm/s, D. (ZIP 1337 kb)
Additional file 2: Mitral Regurgitation. In-plane PC-CMR acquisition in
a three-chamber plane shows severe, eccentric mitral regurgitation.
(ZIP 828 kb)
Additional file 3: Patent Ductus Arteriosus. In-plane PC-CMR
acquisition in an oblique sagittal plane shows continuous flow from the
aorta to the pulmonary artery via a persistent PDA. (ZIP 721 kb)
Additional file 4: Ventricular Septal Defect. In-plane PC-CMR
acquisition in a horizontal long-axis plan with velocity encoding in the
anterior-posterior direction indicates little flow across the large anatomic
defect shown in Fig. 6, consistent with Eisenmenger physiology.
(ZIP 82 kb)
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